Folia Parasitologica 67:034 (2020) | DOI: 10.14411/fp.2020.034

Infection with Toxoplasma gondii can promote chronic liver diseases in HIV-infected individuals

Ihor H. Hryzhak
Ivano-Frankivsk National Medical University (Ivano-Frankivsk, Ukraine);
Ivano-Frankivsk Regional Center for AIDS Prevention and Fight (Ivano-Frankivsk, Ukraine)

Liver pathologies and infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) are widespread among HIV-infected patients. However, a possible contribution of toxoplasmosis to the development of various forms of liver diseases in HIV-infected individuals has not yet been determined. This research is a retrospective cohort study. Medical cards of 907 HIV-positive patients, including 119 individuals who died, were studied. The patients were divided into two groups: 531 patients were seropositive to T. gondii and 376 seronegative. General liver pathology was more widespread among patients seropositive to T. gondii than in seronegative patients (63.1 ± 2.1% and 51.9 ± 2.6%, respectively, p < 0.001). The association of seropositive to T. gondii with general liver pathology is weak both in the whole cohort (Pearson's contingency coefficient C = 0.112), and among the deceased patients (C = 0.228). Chronic HBV-HCV coinfection was more common in the seropositive than in seronegative individuals as it was found both in entire cohorts (26.0 ± 1.9% and 18.6 ± 2.0%, respectively, p = 0.010) and in died patients (31.0 ± 5.5% and 14.6 ± 5.1%, respectively, p = 0.041). Toxoplasma gondii had a weak role in distributing of HBV-HCV coinfection between cohorts (C = 0.187). In both cohorts in patients with chronic hepatitis, regardless of its etiology, there was no significant difference in alanine transaminase activity (ALT). Cirrhosis of the liver occurred 4.5 times more often in deceased seropositive patients than in the entire seropositive cohort (23.9 ± 5.1 and 5.3 ± 2.0, respectively, p = 0.0006) whereas it no significantly increased in seronegative cohort (10.4 ± 4.4 against 4.8 ± 1.1, p > 0.05). In them T. gondii is weakly involved in cirrhosis formation (C = 0.168). Thus, in HIV-infected patients, T. gondii is a weak nonspecific adjunct that supports chronic liver inflammation and progression of cirrhosis, regardless of etiology, but does not influence the degree of hepatitis activity. The increased prevalence of HBV-HCV coinfection in patients seropositive for T. gondii may be related to their risk factor behaviour associated with uncontrolled blood contacts.

Keywords: Toxoplasma gondii, HIV, infection, liver

Received: February 11, 2020; Revised: July 20, 2020; Accepted: August 25, 2020; Published online: November 27, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hryzhak, I.H. (2020). Infection with Toxoplasma gondii can promote chronic liver diseases in HIV-infected individuals. Folia Parasitologica67, Article 2020.034. https://doi.org/10.14411/fp.2020.034
Download citation

References

  1. Alvarado-Esquivel C., Torres-Berumen J.L., Estrada-Martínez S., Liesenfeld O., Mercado-Suarez M.F. 2011: Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population. Parasit. Vectors 4: 75. Go to original source... Go to PubMed...
  2. Atilla A., Aydin S., Demirdöven A.N., Kilic S.S. 2015: Severe toxoplasmic hepatitis in an immunocompetent patient. Jpn. J. Infect. Dis. 68: 407-409. Go to original source... Go to PubMed...
  3. Bonacini M., Kanel G., Alamy M. 1996: Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature. Am. J. Gastroenterol. 91: 1838-1840.
  4. Castellares C., Barreiro P., Martín-Carbonero L., Labarga P., Vispo M.E., Casado R., Galindo L., Garcia-Gasko P., Garcia-Samaniego J. 2008: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J. Viral. Hepat. 15: 165-172. Go to original source... Go to PubMed...
  5. CDC 2017: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (US). HIV and Viral Hepatitis. (Accessed 28 April, 2017) URL: https://www.cdc.gov/hiv/pdf/library_factsheets_hiv_and_viral_hepatitis.pdf
  6. Chaddha D.S., Kalra S.P., Singh A.P., Gupta R.M., Sanchetee P.C. 1999: Toxoplasmic encephalitis in acquired immunodeficiency syndrome. J. Assoc. Physicians India 47: 680-684. Go to PubMed...
  7. Dardé M.L., Ajzenberg D., Smith J. 2011: Population structure and epidemiology of Toxoplasma gondii. In L.M. Weiss, K. Kim (eds.), Toxoplasma Gondii: The Model Apicomplexan: Perspectives and Methods. Academic Press, Cambridge, pp. 49-80. Go to original source...
  8. Doğan N., Kabukçuoğlu S., Vardareli E. 2007: Toxoplasmic hepatitis in an immunocompetent patient. Turkiye Parazitol. Derg. 31: 260-263. Go to PubMed...
  9. El-Rehim El-Henavy A.A., Abdel-Razik A., Zakaria S., Elhammady D., Saudy N., Azab S.M. 2015: Is toxoplasmosis a potential risk factor for liver cirrhosis? Asian Pac. J. Trop. Med. 8: 784-791. Go to original source... Go to PubMed...
  10. El-Nahas H.A., El-Tantawy N.L, Farag R.E., Alsalem A.M. 2014: Toxoplasma gondii infection among chronic hepatitis C patients: a case-control study. Asian Pac. J. Trop. Med. 7: 589-593. Go to original source... Go to PubMed...
  11. Flegr J. 2007: Effects of Toxoplasma on Human Behavior. Schizophrenia Bull. 33: 757-760. Go to original source... Go to PubMed...
  12. Flegr J., Havlícek J., Kodym P., Malý M., Smahel Z. 2002: Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2: 11. Go to original source... Go to PubMed...
  13. Flegr J., Prandota J., Sovicková M., Israili Z.H. 2014: Toxoplasmosis - a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PloS ONE. 9: e90203. Go to original source... Go to PubMed...
  14. Furtado J.M., Smith J.R., Belfort R.jr., Gattey D., Winthrop K.L. 2011: Toxoplasmosis: a global threat. J. Glob. Infect. Dis. 3: 281-284. Go to original source... Go to PubMed...
  15. García-García C., Castillo-Álvarez F., Azcona-Gutiérrez J.M., Herraiz M.J., Ibarra V., Oteo J.A. 2015: Spinal cord toxoplasmosis in human immunodeficiency virus infection/acquired immunodeficiency syndrome. Infect. Dis. (Lond). 47: 277-282. Go to original source... Go to PubMed...
  16. Gazzinelli R., Xu Y., Hieny S., Cheever A., Sher A. 1992: Simultaneous depletion of CD4 and CD8 T-lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149: 175-180. Go to original source... Go to PubMed...
  17. Goïta D., Karambe M., Dembélé J.P. , Sogoba D., Sidibe A.F., Diaby S., Cisse I.A., Fongoro S., Dao S. 2012: Cerebral toxoplasmosis during AIDS in the infectious diseases department of Point-G Teaching Hospital, Bamako, Mali. Mali Med. 27: 47-50.
  18. He J.-J., Ma J., Elsheikha H.M., Song H.-Q., Zhou D.-H., Zhu X.-Q. 2016: Proteomic profiling of mouse liver following acute Toxoplasma gondii infection. PLoS ONE 11: e0152022. Go to original source... Go to PubMed...
  19. Huang J., Zhang H., Liu S., Wang M., Wan B., Velani B., Zhu Y., Lin S. 2018: Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease? - A population-based study. BMC Infect. Dis. 18: 629. Go to original source... Go to PubMed...
  20. Jian-Feng H., Jian-Ping X., Ru-Jin X., Chun-Yan Q. 2018: [Investigation on Toxoplasma gondii infection in liver disease patients in Hangzhou City.] Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 30: 322-324. (In Chinese.) Go to PubMed...
  21. Jones J.L., Kruszon-Moran D., Wilson M. McQuillan G., Navin T., McAuley J.B. 2001: Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am. J. Epidemiol. 154: 357-365. Go to original source... Go to PubMed...
  22. Kung D.H., Hubenthal E.A., Kwan J.Y., Shelburne S.A., Goodman J.C., Kass J.S. 2011: Toxoplasmosis myelopathy and myopathy in an AIDS patient: a case of immune reconstitution inflammatory syndrome? Neurologist 17: 49-51. Go to original source... Go to PubMed...
  23. Lafferty K.D. 2006: Can the common brain parasite, Toxoplasma gondii, influence human culture? Proc. R. Soc. B., Biol Sci. 273: 2749-2755. Go to original source... Go to PubMed...
  24. Lang Z.W., Dao W.B., Zhang F.J., Shi X.H., Ma Z.C., Ma P.Q., Shen B., Lü H.B. 2005: [A pathological study on liver tissues of patients with HIV infection.] Zhonghua Gan Zang Bing Za Zhi. 13: 930-932. (In Chinese.) Go to PubMed...
  25. Lytvynenko M.V. 2007: [Etiological structure and peculiarities of liver damage at HIV infection]. Patolohiya 4: 43-46. (In Ukrainian.)
  26. Marra C.M. 2018: Central nervous system infection with Toxoplasma gondii. Handb. Clin. Neurol. 152: 117-122. Go to original source... Go to PubMed...
  27. Masek K.S., Hunter Ch.A. 2013: Pro-inflammatory responses in macrophages during Toxoplasma gondii infection. Madame Curie Bioscience Database[Internet]. © 2000-2013, Landes Bioscience. URL: https://www.ncbi.nlm.nih.gov/books/NBK5976/ (Accessed 29 April, 2017).
  28. Montoya J.G., Liesenfeld O. 2004: Toxoplasmosis. Lancet. 363: 1965-1976. Go to original source... Go to PubMed...
  29. Nadwa A.J.M., Muthear N.D. 2012: Liver function test in toxoplasmosis. Ann.Coll. Med. 38: 68-72. Go to original source...
  30. Nagwa M.E.S, Manar E.R., Mohamed E.R. 2016: Toxoplasma gondii infection and chronic liver diseases: evidence of an association. Trop. Med. Infect. Dis. 1: 7. Go to original source... Go to PubMed...
  31. Nunura J., Vásquez T., Endo S., Salazar D., Rodriguez A., Pereyra S., Solis H. 2010: Disseminated toxoplasmosis in an immunocompetent patient from Peruvian Amazon. Rev. Inst. Med. Trop. São Paulo. 52: 107-110. Go to original source... Go to PubMed...
  32. Oksenhendler E., Charreau I., Tournerie C., Azihary M., Carbon C., Aboulker J.P. 1994: Toxoplasma gondii infection in advanced HIV infection. AIDS 8: 483-487. Go to original source... Go to PubMed...
  33. Qurishi N., Kreuzberg C., Luchters G., Effenberger W., Kupfer B.., Sauerbruch T., Rockstroh J.K., Spengler U. 2003: Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 362: 1708-1713. Go to original source... Go to PubMed...
  34. Rabaud C., May T., Amiel C., Katlama C., Leport C., Ambroise-Thomas P., Canton P. 1994: Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey. Medicine (Baltimore) 73: 306-314. Go to original source... Go to PubMed...
  35. Rodriguez-Mendez M.L., Gonzalez-Quintela A., Aguilera A., Barrio E. 2000: Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am. J. Gastroenterol. 95: 1316-1322. Go to original source... Go to PubMed...
  36. Trojan A., Kreuzer K.A., Flury R., Schmid M., Schneider J., Schröder S. 1998: Liver changes in AIDS. Retrospective analysis of 227 autopsies of HIV-positive patients. Pathologe. 19: 194-200. Go to original source... Go to PubMed...
  37. Veeranoot N. 2017: Toxoplasma gondii and HIV: a never-ending story. Lancet 4: E146-E147. Go to original source... Go to PubMed...
  38. Vidal J.E. 2019: HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J. Int. Assoc. Provid. AIDS Care 18: 1-20. Go to original source... Go to PubMed...